# Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis

> **NCT03122613** · NA · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 29 (actual)

## Conditions studied

- Ulcerative Colitis in Remission

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03122613
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-19
- **Primary completion:** 2020-05-22
- **Final completion:** 2020-05-22
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Decision made by team of investigators
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122613, "Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03122613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*